Ameloblastin fusion protein enhances pulpal healing and dentin formation in porcine teeth.
Ameloblastin (Ambn, also named "amelin" or "sheathlin") is a protein participating in enamel formation and mesenchymal-ectodermal interaction during early dentin formation in developing teeth. Experiments have demonstrated an association between Ambn expression and healing of acute pulp wounds. The purpose of this study was to investigate if local application of recombinant fusion Ambn (rAmbn) could influence reparative dentin formation in pulpotomized teeth. In this randomized, double-blinded study, pulpotomy was performed in 28 lower central incisors in 17 adult miniature pigs. Following the surgical procedure, the exposed pulp tissue was covered either with rAmbn or with calcium hydroxide. After 2, 4, or 8 weeks, the teeth were extracted and examined by histomorphometry and immunohistochemistry using antibodies against porcine ameloblastin, collagen type I, and dentin sialoprotein (DSP). In rAmbn-treated teeth, a substantial amount of newly formed reparative dentin was observed at the application site, completely bridging the pulpal wound. Dentin formation was also observed in calcium hydroxide-treated teeth; however, the amount of reparative dentin was significantly smaller (P < 0.001) than after rAmbn treatment. Immunohistochemistry confirmed that the new hard tissue formed was similar to dentin. This is the first time a direct link between ameloblastin and dentin formation has been made in vivo. The results suggest potential for rAmbn as a biologically active pulp-dressing agent for enhanced pulpal wound healing and reparative dentin formation after pulpotomy procedures.
Nakamura
Y
Y
Department of Clinical Cariology and Endodontology, School of Dentistry, Showa University, 2-1-1, Kitasenzoku, Ohta-ku, Tokyo, 145-8515, Japan. yukio@senzoku.showa-u.ac.jp
Slaby
I
I
Spahr
A
A
Pezeshki
G
G
Matsumoto
K
K
Lyngstadaas
S P
SP
D000818:Animals; D003746:Dental Enamel Proteins / Q000235:genetics*; D003782:Dental Pulp / Q000187:drug effects* / Q000378:metabolism; D003788:Dental Pulp Diseases / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D003804:Dentin / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D003810:Dentinogenesis / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000494:pharmacology / Q000627:therapeutic use*; D012038:Regeneration / Q000187:drug effects* / Q000502:physiology; D034421:Sus scrofa; D018677:Tooth Injuries / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects / Q000502:physiology
C098519:Ambn protein, rat; D003746:Dental Enamel Proteins; D011993:Recombinant Fusion Proteins